ClaroNav Kolahi has received certification under the European Union Medical Device Regulation (MDR) for its Navient Surgical Navigation System, covering the Navient Image Guided Navigation System and its reusable surgical instruments, allowing the company to continue offering Navient throughout the European Union under the EU MDR regulatory framework.
Newly cleared CraniUS® Plate configuration, designated NeuroPASS 2, adds an opening designed to accommodate an implantable intracranial pressure sensor; issued patent protects the integrated drug delivery architecture at the heart of NeuroPASS 3.
TOLEDO, Ohio, Oct. 7, 2026 /PRNewswire/ — True Indicating, LLC today announced they received FDA clearance of InstaTRU™, an instant biological indicator for steam sterilization cycles that provides results in just 20 seconds. Using spore-based technology, InstaTRU™ confirms the efficacy of a steam sterilization cycle without requiring an incubator or reader.
Their new study, published Oct. 7 in Nature, solves a decades-old scientific puzzle and reveals that a critical inflammatory signaling pathway doesn’t just summon immune cells to the place where they’re needed—it also protects healthy cells from being damaged by the immune response.
A research team led by Professor Sungsu Park of the School of Mechanical Engineering and Professor Byung Mook Weon of the School of Advanced Materials Science and Engineering at Sungkyunkwan University (SKKU) has developed a compact, centimeter-scale microfluidic “Herd-Immunity-on-a-Chip” platform that recreates key features of viral transmission in human societies within a controllable laboratory system.
A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.
A research team has developed an anticancer treatment platform that simultaneously targets cancer cells and the surrounding cells that support them while blocking communication between the two.
Researchers have carried out the first single-cell analysis of mitochondrial DNA in a population of brainstem neurons that are particularly vulnerable to degeneration in Parkinson’s disease.
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.